We first tested whether any of the 116 CT-X genes were differentially expressed in PBMC derived RNA from a discovery set of 12 NSCLC lung cancer patients and 7 control patients with smoking related benign lung diseases including COPD and/or benign granulomatous inflammation. This evidence concerns the gene CYP27A1 and lung cancer.